CONCORD BIOTECH
|
The Current P/S Ratio of CONCORD BIOTECH is 12.50.
| Share Price | ₹1,260.8 | Jul 08,2026 |
| Market Cap | ₹13,188.0 Cr | |
| Sales-TTM | ₹1,054.9 Cr | TTM-Consolidated Results |
| Price/Sales | 12.50x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of CONCORD BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹13,188.0 Cr] as on Jul 08,2026
(/) Sales [ ₹1,054.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 12.50x ]
Thus, for CONCORD BIOTECH , the investors are currently willing to pay '12.50 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of CONCORD BIOTECH !
The chart below summarizes the trend in P/S Ratio of CONCORD BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of CONCORD BIOTECH
PS Ratio Performance Analysis for CONCORD BIOTECH
- CONCORD BIOTECH 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 8.07x.
- CONCORD BIOTECH 's operated at median p/e ratio of 10.07x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/e ratio peaked in Mar2024 at 15.66x.
- CONCORD BIOTECH 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does CONCORD BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| CONCORD BIOTECH | 1,054.9 | 12.50 | 13,188.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.75 | 452,982.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.98 | 179,361.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.78 | 164,737.0 |
| CIPLA LTD | 28,162.6 | 4.11 | 115,655.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.34 | 112,573.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.20 | 102,795.0 |
| LUPIN LTD | 27,958.0 | 4.02 | 112,363.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.22 | 114,613.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.66 | 89,580.6 |
| LAURUS LABS LTD | 6,812.9 | 11.65 | 79,403.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs CONCORD BIOTECH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.66x |
| Max industry PS | 16.98x |
| Median industry PS | 7.20x |
| Average industry PS | 7.84x |
You may also like the below Video Courses